The 84th Scientific Sessions of the American Diabetes Association took place in Orlando, Florida, June 21–24, 2024, and featured a plethora of research on the application of Continuous Glucose Monitors. The use of CGM in people with type 2 diabetes was the subject of many abstracts presented at this symposium. This is a synopsis of the main conclusions made.
The Study Highlights The Cost-Effectiveness Of Real-Time Continuous Glucose Monitoring Or RT-CGM.
- Location: Australia
- Focus: Payor-perspective clinical outcomes and medical cost simulation for diabetes.
- Findings: It is anticipated that RT-CGM users will live longer, with better quality-adjusted years.
- Additional Expenses: AUD$ 14,117
- Insignificant Cost-Effectiveness Ratio: AUD$ 22,736, far less than the AUD$ 50,000 cutoff.
- Reduction of Complications: Neuropathy (8.7%), diabetic eye (17.7%), kidney (21.1%), and cardiovascular (2.5%).
Sensitivity Evaluations
Cost-effectiveness ratios of AUD$ 17,976, AUD$ 13,220, and AUD$ 8464 resulted from cost reductions of 10%, 20%, and 30%, respectively.
Conclusion
In conclusion, even with a 30% cost increase, RT-CGM is still cost-effective. In Australia, there is support for increasing payment for RT-CGM because of the notable decrease in diabetes complications.
Other Prominent Abstracts
RT-CGM vs. Self-Monitoring for Type 2 Diabetes Cost-Effectiveness
- Researchers: Simmons D, Norman GJ, Ahmed M, Alshannaq H.
- Important Findings: Significant financial savings as a result of fewer complications from diabetes.
- Synopsis: 1036-P
Experiences of Chinese Americans with Type 2 Diabetes Using CGM
- Researchers: Chen K, Zheng Y, Greenlee MD, and others.
- Important Findings: Detailed accounts of this demographic’s CGM use experiences and results.
- Synopsis: 1017-P
The Combined Impact of Antidiabetic Medication and CGM
- Researchers: Nemlekar P, Hannah K, and Norman GJ are the researchers.
- Important Findings: Associated with lower A1C values in individuals with type 2 diabetes.
- Synopsis: 1914-LB
The Best Time to Wear CGM for People Who Don’t Wear Insulin
- Researchers: Curran M, Barua S, Upadhyay DA, et al.
- Important Findings: CGM wears time recommendations to maximize results.
- Synopsis: 1907-LB
RT-CGM for Latino Patients with Culturally Appropriate Education
- Researchers: Wright L, Montour L, Ehrhardt NM, et al.
- Important Findings: Effects of RT-CGM in conjunction with culturally appropriate instruction.
- Synopsis: 1930-LB
In Summary
The 84th Scientific Sessions of the American Diabetes Association featured studies that demonstrated the growing significance of continuous glucose monitors (CGMs) in the treatment of type 2 diabetes. The advantages of CGM technology are becoming more and more clear, ranging from cost-effectiveness to better clinical outcomes and individualized instruction. These results highlight the potential of Continuous Glucose Monitors or CGMs to revolutionize diabetes treatment, making them an invaluable tool for managing type 1 and type 2 diabetes.
Citations
- Cost-effectiveness of self-monitoring blood glucose versus real-time continuous glucose monitoring (CGM) in individuals with type 2 diabetes receiving intensive insulin therapy in Australia, by Alshannaq H, Ahmed M, Norman GJ, Simmons D. Delivered at Abstract 1036-P from the American Diabetes Association’s 84th Scientific Sessions, held in Orlando, Florida, June 21–24, 2024.
- Chen K, Zheng Y, Greenlee MD, et al. Chinese Americans with type 2 diabetes have experience utilizing continuous glucose monitors. Delivered at: Abstract 1017-P from the American Diabetes Association’s 84th Scientific Sessions, held in Orlando, Florida, June 21–24, 2024.
- Nemlekar P, Norman GJ, and Hannah K. The relationship between improved A1C in type 2 diabetics and the combined effects of CGM and anti-diabetic drugs. Delivered at: 84th Scientific Sessions of the American Diabetes Association; Orlando, FL; June 21–24, 2024. 1914-LB.
- Barua S, Curran M, Upadhyay DA, et al. Calculating the ideal duration of CGM wear for those with type 2 diabetes who are not taking insulin. Delivered at: Abstract 1907-LB from the American Diabetes Association’s 84th Scientific Sessions, held in Orlando, Florida, June 21–24, 2024.
- Wright L, Montour L, Ehrhardt NM, et al. a randomized study that combined culturally appropriate education with real-time continuous glucose monitoring (RT-CGM) for Latino patients with type 2 diabetes (DM). Delivered at: Abstract 1930-LB from the American Diabetes Association’s 84th Scientific Sessions, held in Orlando, Florida, June 21–24, 2024.
Explore More Blood Glucose Monitors and Continuous Glucose Monitors to Track Diet
FAQs
What justifies the use of Continuous Glucose Monitors or CGMs for non-diabetic uses?
Non-diabetics are using Continuous Glucose Monitors or CGMs due to growing interest in biohacking and tailored nutrition. These people use CGMs to monitor their blood sugar levels and to learn how their diet and lifestyle choices influence them.
What subject matter did the research papers presented at the 84th Scientific Sessions of the American Diabetes Association focus on?
The research looked at several elements of type 2 diabetes management with CGM technology, including cost-effectiveness, clinical results, and user experiences across various demographic groups.
Regarding the cost-effectiveness of RT-CGM for patients with type 2 diabetes, what findings did the Australian study make?
Due to the considerable decrease in diabetes-related complications, the study, which simulated diabetic clinical outcomes and medical expenses from the payer’s point of view, concluded that RT-CGM is cost-effective even with higher expenditures.
According to the studies, how did Chinese Americans with type 2 diabetes benefit from using Continuous Glucose Monitors or CGMs?
The study on Chinese Americans concentrated on their experiences with continuous glucose monitoring (CGM), emphasizing the unique advantages and difficulties this population faces in using CGM technology to manage type 2 diabetes.
What was the combined impact of using a CGM and using anti-diabetic medications?
Studies showed that individuals with type 2 diabetes who used CGM in addition to anti-diabetic drugs had better A1C readings, indicating better glycemic control.
How did researchers determine the ideal amount of time for type 2 diabetics who do not take insulin to use a CGM?
The study determined the ideal duration of CGM wear for those with type 2 diabetes who are not taking insulin and also offered suggestions for efficient use.
What was the result of providing Latino patients with RT-CGM together with culturally appropriate education?
According to randomized research, Latino individuals with type 2 diabetes who received culturally appropriate education along with RT-CGM had far better diabetes management.
What are the general advantages of type 2 diabetes management with Continuous Glucose Monitors or CGMs?
Continuous glucose monitors, or CGMs, offer patients with diabetes ongoing monitoring that helps prevent hypo- and hyperglycemia, raise A1C levels, lessen complications, and improve overall quality of life.
What is the significance of increasing CGM reimbursement in the management of type 2 diabetes?
By increasing reimbursement, more people would be able to benefit from better diabetes care and fewer complications as Continuous Glucose Monitors become more widely available.
